iCAD Reports Financial Results for Fourth Quarter and Fiscal Year Ended December 31, 2024

Provided By GlobeNewswire

Last update: Mar 19, 2025

NASHUA, N.H., March 19, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) ("iCAD" or the "Company") a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast health solutions, today reported its financial and operating results for the fourth quarter and full year ended December 31, 2024.